Specialty Pharmacy Network

Claritas Rx And Turning Point Form Partnership on Specialty Pharmacy Analytics | 9/15/2020

By STS News Desk Claritas Rx , a data integration and analytics company focused on specialty biopharmaceutical distribution channels, announced today that it has partnered with Turning Point , an innovative specialty pharmacy network comprised of the largest independent, top-performing specialty pharmacies, to provide biopharmaceutical manufacturers in-depth analytics and insight based on data from the Turning Point specialty pharmacy network . Read More: Birdie Announces Appointment Of Market Research Veteran Ted …

Claritas Rx And Turning Point Form Partnership on Specialty Pharmacy Analytics | PR Newswire | 9/14/2020

PRNewswire/ – Claritas Rx, a data integration and analytics company focused on specialty biopharmaceutical distribution channels, announced today that it has partnered with Turning Point, an innovative specialty pharmacy network comprised of the largest independent, top-performing specialty pharmacies, to provide biopharmaceutical manufacturers in-depth analytics and insight based on data from the Turning Point specialty pharmacy network . “Claritas is the perfect partner due to the cultural fit and expertise,” said …

Follow Specialty Pharmacy Network:    

Claritas Rx And Turning Point Form Partnership on Specialty Pharmacy Analytics | Benzinga | 9/14/2020

SOUTH SAN FRANCISCO, Calif. , Sept. 14, 2020 /PRNewswire/ – Claritas Rx, a data integration and analytics company focused on specialty biopharmaceutical distribution channels, announced today that it has partnered with Turning Point, an innovative specialty pharmacy network comprised of the largest independent, top-performing specialty pharmacies, to provide biopharmaceutical manufacturers in-depth analytics and insight based on data from the Turning Point specialty pharmacy network . “Claritas is the perfect partner due …

Claritas Rx And Turning Point Form Partnership on Specialty Pharmacy Analytics | 9/14/2020

… Analytics SOUTH SAN FRANCISCO, Calif. , Sept. 14, 2020 /PRNewswire/ – Claritas Rx, a data integration and analytics company focused on specialty biopharmaceutical distribution channels, announced today that it has partnered with Turning Point, an innovative specialty pharmacy network comprised of the largest independent, top-performing specialty pharmacies, to provide biopharmaceutical manufacturers in-depth analytics and insight based on data from the Turning Point specialty pharmacy network . “Claritas is the perfect partner …

Aetna unveils plan nudging members to CVS clinics, pharmacies | Healthcare Dive | 9/1/2020

… an important validation point of our ability to impact medical costs through our consumer-facing assets,” he said. The new Aetna Connected plan also includes a 24/7 CVS pharmacist helpline and access to CVS’ specialty pharmacy network , home infusion services and managed pharmacy network, which includes non-CVS drugstores like Walmart and Kroger. Members will also have access to Aetna’s network of about 1,250 primary care doctors, 8,300 specialists, 13 …

Indy Health Insurance Company Seeking Investor Partners | PR Newswire | 7/22/2020

… move from surviving the current U.S. drug pricing crisis to thriving,” said Ms. Atkinson. In addition, Indy Health Independent Preferred Network members will have better reimbursements, no restrictions to mail and an independent Preferred Specialty Pharmacy Network . Through Indy Health Insurance Company, Medicare-D plan independent pharmacies will ultimately be able to create their own formulary, medication therapy management services and negotiate their own rebates through an independently owned, sustainable …

The specialty pharmacy divide: How health systems and payers can find common ground | Becker’s Hospital Review | 7/8/2020

… enter more risk-based contracts with payers. However, when it comes to establishing a specialty pharmacy service, they often face challenges related to accreditation, regulatory changes, and access to limited distribution drugs and payer specialty pharmacy network s, Dr. Buller said. Health systems see payers as being driven solely by the bottom line, willing to sacrifice care quality for cost. While cost is a primary decision-maker for payers, providers don’t …

Kyle Skiermont to join Prime Therapeutics as senior vice president, specialty pharmacy and home delivery services | PR Newswire | 4/23/2020

… role. He will lead Prime’s future strategy for specialty pharmacy and home delivery services. Skiermont will have responsibility for all aspects of the specialty pharmacy delivery channel including specialty product and clinical program development, specialty pharmacy network s and a specialty drug management model. He will bring his rich clinical experience and focus on patient experience to shape a specialty delivery approach designed to improve member quality, experience and value. His …

scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2019 Financial Results and Provides Business Update - GuruFocus.com | 3/24/2020

… FUROSCIX near completion, the Company has begun to turn attention to pre-commercialization efforts. The Company will be focused on specific pre-commercialization activities including establishing a managed care advisory board, contracting with a specialty pharmacy network , and conducting market research to prepare FUROSCIX product messaging and positioning. These pre-commercialization activities will be staged as appropriate to efficiently follow FUROSCIX’s regulatory progress. As part of these efforts, the Company …

scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2019 Financial Results and Provides Business Update | Financial Buzz | 3/24/2020

… FUROSCIX near completion, the Company has begun to turn attention to pre-commercialization efforts. The Company will be focused on specific pre-commercialization activities including establishing a managed care advisory board, contracting with a specialty pharmacy network , and conducting market research to prepare FUROSCIX product messaging and positioning. These pre-commercialization activities will be staged as appropriate to efficiently follow FUROSCIX’s regulatory progress. As part of these efforts, the Company …

ACR Advocates Against Payer Mandates on Specialty Pharmacy Acquisition of In-Office Treatments | 3/23/2020

Scientist Development Award Winner Probes Ethnic Disparities in Lupus Blue Cross Blue Shield of Tennessee (BCBST) announced in fall 2019 that all specialty drugs would have to be acquired through the BCBST specialty pharmacy network as of Jan. 1, 2020. After hearing significant opposition from stakeholders, it pushed back the implementation date to July 1, 2020. If BCBST moves forward with this policy, the ACR is concerned that other payers …

mCig Inc. Signs Letter of Intent With Multi-State Licensed PCAB Accredited Compounding, Retail, and Specialty Pharmacy Network | Globe Newswire | 3/13/2020

JACKSONVILLE, FL, March 13, 2020 (GLOBE NEWSWIRE) – via NEWMEDIAWIRE – mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development, today announced execution of a Letter of Intent (LOI) reflecting the Company’s strategic partnership with NJ based, Kaplan Group d/b/a Medical Home Pharmacy ( http://www.medicalhomepharmacy.com/ , https://www.youtube.com/watch?v=LWqRacr …

mCig Inc. Signs Letter of Intent With Multi-State Licensed PCAB Accredited Compounding, Retail, and Specialty Pharmacy Network | 3/13/2020

Share mCig Inc. Signs Letter of Intent With Multi-State Licensed PCAB Accredited Compounding, Retail, and Specialty Pharmacy Network Mar. 13, 2020 7:00 AM ET Source: mCig, Inc. JACKSONVILLE, FL - ( NewMediaWire ) - March 13, 2020 - mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development, today announced execution of a Letter of …

mCig Inc. Signs Letter of Intent With Multi-State Licensed PCAB Accredited Compounding, Retail, and Specialty Pharmacy Network | The Wapakoneta Daily News | 3/13/2020

JACKSONVILLE, FL 13, 2020 - mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development, today announced execution of a Letter of Intent (LOI) reflecting the Company’s strategic partnership with NJ based, Kaplan Group d/b/a Medical Home Pharmacy ( http://www.medicalhomepharmacy.com/ , https://www.youtube.com/watch?v=LWqRacr-ZRY ). Kaplan Group has an …

mCig, Inc. (MCIG) Signs Letter of Intent | Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™ | 3/13/2020

mCig Inc. Signs Letter of Intent With Multi-State Licensed PCAB Accredited Compounding, Retail, and Specialty Pharmacy Network mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development, today announced execution of a Letter of Intent (LOI) reflecting the Company’s strategic partnership with NJ based, Kaplan Group d/b/a Medical …

mCig Inc. Signs Letter of Intent With Multi-State Licensed PCAB Accredited Compounding, Retail, and Specialty Pharmacy Network | Financial Buzz | 3/13/2020

JACKSONVILLE, FL, via NEWMEDIAWIRE — mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development, today announced execution of a Letter of Intent (LOI) reflecting the Company’s strategic partnership with NJ based, Kaplan Group d/b/a Medical Home Pharmacy ( http://www.medicalhomepharmacy.com/ , https://www.youtube.com/watch?v=LWqRacr-ZRY ). Kaplan Group has an …

FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month | Physicians Weekly | 1/10/2020

… the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network in the United States within a week, with a wholesale acquisition cost or list price of $32,000 for a 30-day supply, regardless of dosage. The list price is not necessarily what patients …

FDA Approves Blueprint’s Stomach Cancer Therapy Priced at $32,000 Per Month | 1/10/2020

… subset of patients with unresectable or metastatic gastrointestinal stromal tumor (GIST) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation. Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network in the United States within a week, with a wholesale acquisition cost or list price of $32,000 for a 30-day supply, regardless of dosage. The list price is not necessarily what patients …

FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month | News | WIN 98.5 | 1/9/2020

… the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network in the United States within a week, with a wholesale acquisition cost or list price of $32,000 for a 30-day supply, regardless of dosage. The list price is not necessarily what patients …

FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month | News | MIX-FM | 1/9/2020

… the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network in the United States within a week, with a wholesale acquisition cost or list price of $32,000 for a 30-day supply, regardless of dosage. The list price is not necessarily what patients …

FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month | 1/9/2020

… the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network in the United States within a week, with a wholesale acquisition cost or list price of $32,000 for a 30-day supply, regardless of dosage. The list price is not necessarily what patients …

Albertsons Joins AssistRx Specialty Pharmacy Network | 12/19/2019

Albertsons Joins AssistRx Specialty Pharmacy Network Press enter to search Subscribe AssistRx’s integrated access solution, iAssist, was developed to simplify the process and delivery of prescriptions to the pharmacy Albertsons Cos. Specialty Care is now using the AssistRx technology platform to give patients and providers faster access to specialty prescription medications and support services. Via AssistRx’s integrated access solution, iAssist, patient prescription information is captured electronically by Albertsons Specialty Care …

Trellis Rx Helps Patients Secure More Than $13.5 Million in Financial Assistance for Specialty Medications in First Ten Months Of 2019 | Business Wire | 12/3/2019

… Rx has also fostered a number of partnerships with nationally recognized payors and pharmaceutical companies on behalf of its health system partners. For example, Trellis Rx helped North Memorial Health gain access to the specialty pharmacy network of its largest commercial payor. Trellis Rx is also partnering with pharmaceutical manufacturers and North Memorial Health providers on clinical outcomes studies in oncology and rheumatology. In addition to fostering relationships with health …

Account Manager - Managed Care - Minneapolis - Minneapolis, MN, , USA #jobs #Minneapolis pls RT | 11/23/2019

Job Detail for Account Manager - Managed Care - Minneapolis Job Location: ExceleraRx Corp - A National Specialty Pharmacy Network , Minneapolis, MN, , USA Job Detail for Account Manager - Managed Care - Minneapolis Job Location: ExceleraRx Corp - A National Specialty Pharmacy Network , Minneapolis, MN, , USA Jobs In Account Manager Managed Care … Jobs In Account Manage… Jobs In Account M… Position Summary:The Account Manager Managed Care is a corporate-based position responsible for overseeing payer …

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | Malvern Daily Record | 11/21/2019

Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients with relapsed and refractory MCL is an important advancement in fighting this devastating disease,” said Paul …

Food and Drug Administration

FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month | Physicians Weekly | 1/10/2020

Food and Drug Administration approved Blueprint Medicines Corp’s oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday. The FDA’s decision makes the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | Business Wire | 11/21/2019

… BUSINESS WIRE)–Nov 21, 2019– Onco360 ®, the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with … research-based biotechnology company, and was approved by the U.S. Food and Drug Administration (FDA) to treat adult patients with MCL on November 14, 2019. The FDA’s approval of BRUKINSA is based on efficacy results …

Coordinated Care

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | PRWeb | 8/6/2019

Excelera® Specialty Pharmacy Network Welcomes HonorHealth Share Article Second Arizona-based member to join the network, serving Scottsdale and Phoenix “We are pleased to add HonorHealth to our growing network of high-quality health system … implement and optimize their specialty pharmacies to provide patients with coordinated care and increased access to limited distribution drugs (LLDs). With the membership of HonorHealth, Excelera now boasts a combined network specialty pharmacy revenue of …

Excelera Promotes Troy Polan to Chief Technology Officer | PRWeb | 4/16/2019

… validation and standardization of health data. “Excelera uses its robust data platform to provide key insights demonstrating the value of coordinated care for complex patients,” said Polan. “It will be increasingly important to delve even … time, he has helped to establish and grow the Excelera Specialty Pharmacy Network, which is comprised of integrated delivery networks, health systems and large academic medical centers with a deep commitment to caring for complex …

ExceleraRx

Account Manager - Managed Care - Minneapolis - Minneapolis, MN, , USA #jobs #Minneapolis pls RT | 11/23/2019

Job Detail for Account Manager - Managed Care - Minneapolis Job Location: ExceleraRx Corp - A National Specialty Pharmacy Network, Minneapolis, MN, , USA Job Detail for Account Manager - Managed Care - Minneapolis Job Location: ExceleraRx Corp - A National Specialty Pharmacy Network, Minneapolis, MN, , USA Jobs In Account Manager Managed Care … Jobs In Account Manage… Jobs In Account M… Position Summary:The Account Manager Managed Care is a corporate-based position responsible for overseeing payer …

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | PRWeb | 8/6/2019

Excelera® Specialty Pharmacy Network Welcomes HonorHealth Share Article Second Arizona-based member to join the network, serving Scottsdale and Phoenix “We are pleased to add HonorHealth to our growing network of high-quality health system members,” said Brady Atherton, VP Sales and Business Development of ExceleraRx Corp. MINNEAPOLIS The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic …

BeiGene

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | Malvern Daily Record | 11/21/2019

Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients with relapsed and refractory MCL is an important advancement in fighting this devastating disease,” said Paul …

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | BioSpace | 11/21/2019

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 Published: Nov 21, 2019 LOUISVILLE, Ky.–( BUSINESS WIRE )– Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second …

Excelera

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | 8/6/2019

MINNEAPOLIS (PRWEB) August 06, 2019 The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic medical center specialty pharmacies. The Excelera Network has … revenue cycle management, and pharmacy business office. About The Excelera® Specialty Pharmacy Network The Excelera® Specialty Pharmacy Network is comprised of integrated delivery networks, health systems, and large academic medical centers with a deep commitment …

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | PRWeb | 8/6/2019

Excelera® Specialty Pharmacy Network Welcomes HonorHealth Share Article Second Arizona-based member to join the network, serving Scottsdale and Phoenix “We are pleased to add HonorHealth to our growing network of high-quality health system members,” said Brady Atherton, VP Sales and Business Development of ExceleraRx Corp. MINNEAPOLIS The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic …

HonorHealth

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | 8/6/2019

MINNEAPOLIS (PRWEB) August 06, 2019 The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic medical center specialty pharmacies. The Excelera Network has … revenue cycle management, and pharmacy business office. About The Excelera® Specialty Pharmacy Network The Excelera® Specialty Pharmacy Network is comprised of integrated delivery networks, health systems, and large academic medical centers with a deep commitment …

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | PRWeb | 8/6/2019

Excelera® Specialty Pharmacy Network Welcomes HonorHealth Share Article Second Arizona-based member to join the network, serving Scottsdale and Phoenix “We are pleased to add HonorHealth to our growing network of high-quality health system members,” said Brady Atherton, VP Sales and Business Development of ExceleraRx Corp. MINNEAPOLIS The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic …

Paul Jardina

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | Malvern Daily Record | 11/21/2019

Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients with relapsed and refractory MCL is an important advancement in fighting this devastating disease,” said Paul …

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | BioSpace | 11/21/2019

specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients with relapsed and refractory MCL is an important advancement in fighting this devastating disease,” said Paul Jardina, President and CEO, Onco360. “As a specialty pharmacy dedicated to serving people with cancer …